Kejing Ying

4.3k total citations · 1 hit paper
96 papers, 2.4k citations indexed

About

Kejing Ying is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Kejing Ying has authored 96 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 30 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Kejing Ying's work include Lung Cancer Treatments and Mutations (16 papers), RNA modifications and cancer (15 papers) and Advanced Chemical Sensor Technologies (12 papers). Kejing Ying is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), RNA modifications and cancer (15 papers) and Advanced Chemical Sensor Technologies (12 papers). Kejing Ying collaborates with scholars based in China, United States and Thailand. Kejing Ying's co-authors include Ruifeng Zhang, Ping Wang, Yanjie Hu, Hua Su, Yingchang Zou, Fangchun Shao, Liuhong Shi, Xiaohong Wu, Lin Zhou and Liangliang Dong and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Kejing Ying

89 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancer

2021 246 citations Kejing Ying et al. profile →

Peers

Kejing Ying

PRM

ONCOL

Peter Lukáš Austria

Michael Bousamra United States

Stephen Lam Canada

Jonna Skov Madsen Denmark

Xiaohui Du China

Yan Yan China

Baijun Dong China

Jehonathan H. Pinthus Canada

Catharine M. Sturgeon United Kingdom

Peter Lukáš Austria

Kejing Ying

858 ×0.9

PRM

580 ×0.7

885 ×1.6

ONCOL

234 ×0.4

789 ×1.6

Citations per year, relative to Kejing Ying Kejing Ying (= 1×) peers Peter Lukáš

Countries citing papers authored by Kejing Ying

Since Specialization

Citations

This map shows the geographic impact of Kejing Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kejing Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kejing Ying more than expected).

Fields of papers citing papers by Kejing Ying

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kejing Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kejing Ying. The network helps show where Kejing Ying may publish in the future.

Co-authorship network of co-authors of Kejing Ying

This figure shows the co-authorship network connecting the top 25 collaborators of Kejing Ying. A scholar is included among the top collaborators of Kejing Ying based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kejing Ying. Kejing Ying is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ruan, Wenjing, Jing Xu, Fan Yang, Xiaohong Wu, & Kejing Ying. (2024). Tropheryma whipplei infection in the lung of a patient with long COVID: a case report. BMC Infectious Diseases. 24(1). 292–292. 4 indexed citations

Xu, Shan, Xiaohong Wu, Enguo Chen, & Kejing Ying. (2024). Anti‐Helicobacter pylori Infection Treatment and Pulmonary Hypersensitivity: Case Series and Review of the Literature. The Clinical Respiratory Journal. 18(8). e13816–e13816.

Ying, Kejing, Dandan Lv, Yeping Li, et al.. (2024). NanoSHP099‐Targeted SHP2 Inhibition Boosts Ly6C ^low Monocytes/Macrophages Differentiation to Accelerate Thrombolysis. Advanced Science. 11(13). e2308166–e2308166. 1 indexed citations

Zhou, Caicun, Yi Hu, Kejing Ying, et al.. (2023). 540P Phase III study of serplulimab plus chemotherapy as first-line therapy for advanced squamous non-small cell lung cancer: ASTRUM-004 Asian subgroup. Annals of Oncology. 34. S1680–S1680. 1 indexed citations

Jiang, Deming, Xinwei Wei, Yuxuan Zhu, et al.. (2023). Evaluating the efficacy and cardiotoxicity of EGFR-TKI AC0010 with a novel multifunctional biosensor. Microsystems & Nanoengineering. 9(1). 57–57. 4 indexed citations

Li, Yiqing, Hui Zhou, Pan Liu, et al.. (2023). SHP2 deneddylation mediates tumor immunosuppression in colon cancer via the CD47/SIRPα axis. Journal of Clinical Investigation. 133(4). 36 indexed citations

Su, Hua, et al.. (2022). Construction of Risk Assessment Model for Venous Thromboembolism After Colorectal Cancer Surgery: A Chinese Single-Center Study. Clinical and Applied Thrombosis/Hemostasis. 28. 2975255252–2975255252. 12 indexed citations

Xu, Yiming, et al.. (2022). Organoids in lung cancer: A teenager with infinite growth potential. Lung Cancer. 172. 100–107. 7 indexed citations

Yang, Juze, Xinyi Qian, Qiongzi Qiu, et al.. (2022). LCAT1 is an oncogenic LncRNA by stabilizing the IGF2BP2-CDC6 axis. Cell Death and Disease. 13(10). 877–877. 19 indexed citations

10.

Ge, Huiqing, et al.. (2021). Airway Pressure Release Ventilation Mode Improves Circulatory and Respiratory Function in Patients After Cardiopulmonary Bypass, a Randomized Trial. Frontiers in Physiology. 12. 684927–684927. 6 indexed citations

11.

Ge, Huiqing, et al.. (2018). Effect of Nebulizer Location and Spontaneous Breathing on Aerosol Delivery During Airway Pressure Release Ventilation in Bench Testing. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 32(1). 34–39. 10 indexed citations

12.

Ying, Kejing, et al.. (2018). OA08 Efficacy and Safety of Sintilimab Combined with 1st Line Chemotherapy in Advanced Squamous Cell Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 13(12). S1047–S1047. 3 indexed citations

13.

Wang, Xiaohua, Chao Yan, Xiaoling Xu, et al.. (2015). Long noncoding RNA expression profiles of hypoxic pulmonary hypertension rat model. Gene. 579(1). 23–28. 23 indexed citations

14.

Ge, Huiqing, et al.. (2015). High-Level Pressure Support Ventilation Attenuates Ventilator-Induced Diaphragm Dysfunction in Rabbits. The American Journal of the Medical Sciences. 350(6). 471–478. 3 indexed citations

15.

Hu, Xingsheng, Baohui Han, Aiqin Gu, et al.. (2014). A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC). Lung Cancer. 86(2). 207–212. 31 indexed citations

16.

Zou, Yingchang, Lin Wang, Cong Zhao, et al.. (2013). CEA, SCC and NSE levels in exhaled breath condensate—possible markers for early detection of lung cancer. Journal of Breath Research. 7(4). 47101–47101. 40 indexed citations

17.

Yang, Li, Min Lin, Wenjing Ruan, et al.. (2012). Nkx2-1: a novel tumor biomarker of lung cancer. Journal of Zhejiang University SCIENCE B. 13(11). 855–866. 28 indexed citations

18.

Chen, Enguo, et al.. (2010). A large tracheal capillary hemangioma treated with interventional bronchoscopy. Respiratory Medicine CME. 4(2). 60–61. 8 indexed citations

19.

Zhang, Ruifang, et al.. (2010). Diagnostic Value of Transthoracic Doppler Echocardiography in Pulmonary Hypertension: A Meta-Analysis. American Journal of Hypertension. 23(12). 1261–1264. 25 indexed citations

20.

Chen, Enguo, et al.. (2002). Comparison between young and old patients with lung cancer. Chinese Journal of Cancer Research. 14(4). 305–308. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact